Medicine News and Research

RSS

Intraperitoneal chemotherapy prolongs survival for women with advanced ovarian cancer

A study featured in this month's edition of Gynecologic Oncology examines the challenges associated with the administration of intra-abdominal chemotherapy, also known as intraperitoneal (IP) chemotherapy.

8 Jan 2006

Unorthodox vaccine could one day help to prevent or control HIV infection

Researchers at Baylor College of Medicine (BCM) in Houston have reason to believe their unorthodox vaccine could one day help to prevent or control HIV infection, according to a study published in today's edition of Public Library of Science Medicine.

6 Jan 2006

Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses

Older Americans with alcohol problems do not get worse treatment than their sober peers when they are hospitalized for a heart attack, according to new research on Medicare patients across the country.

6 Jan 2006

Link between soft drinks and esophageal cancer debunked

Carbonated soft drink consumption was previously suggested to be linked to the 350 percent increase of adenocarcinoma of the esophagus since the mid-1970s, but researchers at Yale School of Medicine report that the link is unfounded and that there may, in fact, be a decreased risk of this cancer for diet soda drinkers.

6 Jan 2006

Liver cirrhosis in Britain worst in Europe

Britain has had the steepest increase in death rates from liver cirrhosis in western Europe since the 1950s, according to a study in this week’s issue of The Lancet.

6 Jan 2006

DNA polymerase zeta gives cells with damaged DNA a new lease on life

Fortunately, our cells contain many enzymes devoted strictly to detecting and repairing any damage caused by these insults. In fact, failure of these enzymes to make needed repairs to genes can lead to the accumulation of mutations and, eventually, cell death or possibly cancer.

6 Jan 2006

Largest post-mortem study of SARS deaths teaches scientists about the disease

Led by John Nicholls of Hong Kong University, researchers from Hong Kong and from Toronto (two of the cities worst affected by the 2003 SARS outbreak) joined forces for a large and detailed study of the bodies of 32 patients who had died from SARS.

6 Jan 2006

Taking an alternative approach to HIV vaccination

Researchers from Baylor College of Medicine have shown that switching off a molecule that helps regulate dendritic cells, specialized white blood cells that activate the immune system, could help the host fight HIV infection.

6 Jan 2006

Ethnic minority groups must be included in European health research

Despite the knowledge that ethnicity matters in cardiovascular disease, most studies of cardiovascular disease risk have not been designed to yield results that apply to different ethnic groups, report Meghna Ranganathan and Raj Bhopal (of Edinburgh University) in a new study in the international open-access medical journal PLoS Medicine.

6 Jan 2006

Tekes takes part in an extensive stem cell project

Tekes has allocated three million euros to financing a project by the Tampere-based Regea Institute for Regenerative Medicine, the goal of which is to use stem cells in tissue-related technological applications.

6 Jan 2006

Promising new therapy for ulcerative colitis

For people with the chronic disease ulcerative colitis, life can be limited to few social functions and trips away from home.

6 Jan 2006

Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients

A 50-year-old method for delivering chemotherapy directly into the abdomen is making a comeback as investigators have found that it increases survival - by more than a year - in some women with advanced ovarian cancer. Results from a seven-year study of more than 400 patients nationwide are published in the New England Journal of Medicine.

6 Jan 2006

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Data from one of the largest infant vaccine trials ever conducted, published in the New England Journal of Medicine (NEJM), showed GlaxoSmithKline's (GSK) rotavirus vaccine candidate as effective against rotavirus disease (rotavirus gastroenteritis) in the first year of life. Rotavirus is the leading recognized cause of diarrhea-related illness and death among infants and young children.

6 Jan 2006

Research indicates birth control pill could cause long-term problems with testosterone

In the January issue of The Journal of Sexual Medicine, researchers have published a new investigation measuring sex hormone binding globulin (SHBG) before and after discontinuation of the oral contraceptive pill.

6 Jan 2006

Rotateq eliminates the most severe cases of rotavirus

In a study of more than 68,000 infants published in the New England Journal of Medicine, the investigational vaccine Rotateq demonstrated that it can safely prevent 98 percent of severe cases of viral diarrhea and vomiting that account for 2 million hospital visits and 500,000 pediatric deaths each year worldwide.

6 Jan 2006

alphaB-crystallin may be a useful molecular marker to identify women with aggressive breast cancer

A groundbreaking study led by Northwestern University researchers has demonstrated that a protein called alphaB-crystallin, which normally protects cells from stress damage, triggers events that may cause breast cancer when overactive.

6 Jan 2006

Americans don't need to pay the highest prices in the world for prescription drugs!

A study of drug costs around the world revealed proven methods that could be used to reduce costs in the United States, according to a researcher from Wake Forest University School of Medicine.

6 Jan 2006

Hopkins discovery provides molecular marker to assess risk for patients with papillary thyroid cancer

Scientists at Johns Hopkins have found that a mutation in the gene that triggers production of a tumor growth protein is linked to poorer outcomes for patients with papillary thyroid cancer (PTC).

6 Jan 2006

Prospect of personalized medicine places new demands on the evaluation of new medicines

As we enter the era of personalized medicine, it is time to take a fresh look at how we evaluate new medicines and treatments for cancer, according to Donald Berry, Ph.D., professor and chair of the Department of Biostatistics and Applied Mathematics at The University of Texas M. D. Anderson Cancer Center.

6 Jan 2006

Caspase 8 gene halts spread of aggressive childhood cancer

A team of cancer researchers has shown that a gene commonly lost during neuroblastoma tumor formation, one of the most aggressive cancers in babies and children, is in fact a "metastasis suppressor" gene.

6 Jan 2006

Medicine News and Research

Intraperitoneal chemotherapy prolongs survival for women with advanced ovarian cancer

Unorthodox vaccine could one day help to prevent or control HIV infection

Quality of care for acute myocardial infarction in elderly patients with alcohol-related diagnoses

Link between soft drinks and esophageal cancer debunked

Liver cirrhosis in Britain worst in Europe

DNA polymerase zeta gives cells with damaged DNA a new lease on life

Largest post-mortem study of SARS deaths teaches scientists about the disease

Taking an alternative approach to HIV vaccination

Ethnic minority groups must be included in European health research

Tekes takes part in an extensive stem cell project

Promising new therapy for ulcerative colitis

Delivering chemotherapy directly into the abdomen boosts survival in ovarian cancer patients

Data establishes safety profile of new GlaxoSmithKline rotavirus vaccine candidate

Research indicates birth control pill could cause long-term problems with testosterone

Rotateq eliminates the most severe cases of rotavirus

alphaB-crystallin may be a useful molecular marker to identify women with aggressive breast cancer

Americans don't need to pay the highest prices in the world for prescription drugs!

Hopkins discovery provides molecular marker to assess risk for patients with papillary thyroid cancer

Prospect of personalized medicine places new demands on the evaluation of new medicines

Caspase 8 gene halts spread of aggressive childhood cancer

Everything there is to know about biosimilars eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News